GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » ROA %

Biolife Sciences (Biolife Sciences) ROA % : -108.38% (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Biolife Sciences's annualized Net Income for the quarter that ended in May. 2008 was $-3.37 Mil. Biolife Sciences's average Total Assets over the quarter that ended in May. 2008 was $3.11 Mil. Therefore, Biolife Sciences's annualized ROA % for the quarter that ended in May. 2008 was -108.38%.

The historical rank and industry rank for Biolife Sciences's ROA % or its related term are showing as below:

BLFE's ROA % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -2.11
* Ranked among companies with meaningful ROA % only.

Biolife Sciences ROA % Historical Data

The historical data trend for Biolife Sciences's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences ROA % Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
ROA %
-20.93 -161.85 -11.09 -56.55

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.12 -40.75 -113.17 -51.44 -108.38

Competitive Comparison of Biolife Sciences's ROA %

For the Medical Instruments & Supplies subindustry, Biolife Sciences's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolife Sciences's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's ROA % distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's ROA % falls into.



Biolife Sciences ROA % Calculation

Biolife Sciences's annualized ROA % for the fiscal year that ended in Nov. 2007 is calculated as:

ROA %=Net Income (A: Nov. 2007 )/( (Total Assets (A: Nov. 2006 )+Total Assets (A: Nov. 2007 ))/ count )
=-2.046/( (3.474+3.762)/ 2 )
=-2.046/3.618
=-56.55 %

Biolife Sciences's annualized ROA % for the quarter that ended in May. 2008 is calculated as:

ROA %=Net Income (Q: May. 2008 )/( (Total Assets (Q: Feb. 2008 )+Total Assets (Q: May. 2008 ))/ count )
=-3.368/( (3.174+3.041)/ 2 )
=-3.368/3.1075
=-108.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (May. 2008) net income data. ROA % is displayed in the 30-year financial page.


Biolife Sciences  (OTCPK:BLFE) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: May. 2008 )
=Net Income/Total Assets
=-3.368/3.1075
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-3.368 / 7.192)*(7.192 / 3.1075)
=Net Margin %*Asset Turnover
=-46.83 %*2.3144
=-108.38 %

Note: The Net Income data used here is four times the quarterly (May. 2008) net income data. The Revenue data used here is four times the quarterly (May. 2008) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Biolife Sciences ROA % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020